An Agent-Based Model of Combination Oncolytic Viral Therapy and Anti-PD-1 Immunotherapy Reveals the Importance of Spatial Location When Treating Glioblastoma

SIMPLE SUMMARY: A combination of oncolytic viral therapy and immunotherapy provides an alternative option to the standard of care for treating the lethal brain tumor glioblastoma (GBM). Although this combination therapy shows promise, there are many unknown questions regarding how the tumor landscap...

Descripción completa

Detalles Bibliográficos
Autores principales: Storey, Kathleen M., Jackson, Trachette L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582495/
https://www.ncbi.nlm.nih.gov/pubmed/34771476
http://dx.doi.org/10.3390/cancers13215314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582495/
https://www.ncbi.nlm.nih.gov/pubmed/34771476
http://dx.doi.org/10.3390/cancers13215314

Ejemplares similares